The Lifecycle Leader for Roche’s broad RAS Portfolio, including a next-generation KRAS G12C inhibitor, leads the asset strategy and portfolio from research through to patients. The role leads the Life Cycle Team (LCT) and is accountable to the Late Stage Portfolio Committee (LSPC), maximizing product value for patients, society, and the company through an integrated, global, cross-functional strategy. The role shapes the portfolio’s long-term vision in partnership with early development, Pharma Development, Global Pharma Strategy, Medical Affairs leads, and external partners. It supports earlier lifecycle involvement and transition from early to late-stage development, as well as relevant early development asset teams, licensing, and business development activities. The Lifecycle Leader drives integrated decision-making with development, technical, and commercial teams; builds accountability and team capability; and serves as a thought partner to internal and external stakeholders. The role oversees resource requests and utilization, delivery of adjusted net present value (aNPV) commitments to LSPC, and ongoing assessment of asset strategy and value opportunities. It integrates proposals for indications, formulations, devices, diagnostics, digital tools, and evidence generation to address appropriate treatable populations.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior